Pioneer Valley Life Sciences Institute of Baystate Medical & Umass Amherstinc

Nonprofit profile at a glance

EIN
571183126
IRS 990 coverage
2009–2024
Forms available
Form 990 2024
Location
Springfield, MA, USA
Phone
4137947833
Rating confidence
Limited
Sector
Biomedicine, Bioengineering Research

Reported finances

Revenue
$0
Expenses
$234,063
Assets
$590,935
Liabilities
$404,404

Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

13 people listed

People named in this filing

  • PETER REINHART PHD (CHAIR THRU 11/24 THEN VICE CHAIR)
  • PETER FRIEDMANN (VICE CHAIR; DIRECTOR (END 12/24/2024))
  • ANDREW MANGELS (DIRECTOR)

Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.

Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

To improve human health by developing creative new approaches for the diagnosis and treatment of disease.

What it reported doing in 2024

Tissue and cell biorepository description: normal and cancer cells from a diverse cohort of patients is needed to identify cellular mechanisms responsible for the wide variation in responses to therapies among individuals. The effort has emphasized collections of normal breast epithelial cells from participants and development of methods to create stable cell lines representing the genetic and epigenetic diversity in the population of women. Tumor tissues are also available for creating cell and transplant models of breast cancers.accomplishments: breast tissues have been collected for fixation and frozen sample from 670 women. Primary cultures of breast epithelial cells have been dissociated and frozen for approximately 425 women. We have created and characterized immortalized cell lines from 16 participants which are now available to academic researchers. When grown in 3d matrix, the cell lines form ductlike structures to model normal breast and form tumors when exposed to chemicals or when oncogenes are introduced. The ovarian repository contains ovarian tissues and matching bloods from 160 donors.

Operating model

Revenue model
No positive adjusted resources. The filing reports no positive adjusted operating resources.
Distribution model
Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

- The available evidence is not sufficient to produce an overall rating for this filing. This is not a warning sign.

Rating breakdown

  • Financial Efficiency: 69
  • Transparency & Controls: 90
  • Accountability: 76
  • Sustainability: 19
  • Growth: 0

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: Limited
  • Program expense ratio: 91.8%; rating input score 92
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
  • Pay-setting controls: Limited
  • Foreign activity oversight: Limited
  • Grant itemization coverage: Limited
  • Major donor itemization: Limited
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 100%; rating input score 100; 64th percentile among comparable filings
  • Governance controls: 3 of 7 controls in place; rating input score 43
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Fail
    • Document-retention policy: Fail
    • CEO compensation review process: NotApplicable
    • Other executive compensation review process: NotApplicable
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Missing
    • Independent financial-statement audit: Fail

Sustainability

  • Operating margin: Limited
  • Total-asset coverage ratio: 2.52; rating input score 38; 38th percentile among comparable filings
  • Liabilities to assets ratio: 0.68; rating input score 9; 9th percentile among comparable filings
  • Officer compensation ratio: 0%; rating input score 60; 60th percentile among comparable filings

Growth

  • Program expense growth: -3.7% per year; rating input score 0; 41st percentile among comparable filings
  • Revenue growth: -26.3% per year; rating input score 0; 15th percentile among comparable filings
  • Asset growth: -10% per year; rating input score 0; 13th percentile among comparable filings

Details

  • Where the money goes: 91.8% of spending went to programs
  • Governance: 10 of 10 board members independent · 3 of 7 filing controls reported
  • Programs: 3 filed program accomplishments · $215K in reported program spending
  • Leadership: top reported pay $0 · 13 people listed
  • Consistency: 17 of 17 current checks pass
  • Schedules: 3 filed schedules
  • Filing history: 16 filing years from 2009 to 2024
  • Contacts: How to reach this organization
  • Money network: Resolved incoming and outgoing counterparties from filed money flows.
  • Related organizations: Filed and resolved organization relationships.
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • Moderate — Accountability: Governance controls: 3 of 6 not reported.
  • High — Growth: Program expense growth scored 0/100.
  • High — Growth: Revenue growth scored 0/100.
  • Moderate — Sustainability: Total-asset coverage ratio scored 38/100.
  • High — Sustainability: Liabilities to assets ratio scored 9/100.
  • High — Growth: Asset growth scored 0/100.